Articles · Sleep

Sleep Apnea After Menopause

OSA becomes far more common in postmenopausal women, and looks nothing like the textbook.

9 min read · Published May 30, 2026 · Updated August 28, 2026

Sourced from peer-reviewed research and clinical guidelines, cited at the end of this article. How we write about your body.

Sleep Apnea After Menopause

Obstructive sleep apnea (OSA) is a condition in which the upper airway repeatedly collapses during sleep, causing breathing to stop for 10 seconds or more. These pauses fragment sleep, drop blood oxygen levels, and switch on the nervous system’s stress response, with consequences that range from daytime fatigue to substantially higher heart risk.

OSA has long been diagnosed and researched as a men’s condition. Women develop it at much higher rates after menopause, and their symptoms often do not match the picture GPs and sleep specialists are trained to recognise. The result is significant underdiagnosis at exactly the time when OSA risk is highest and its consequences are most serious.

How Common Is OSA After Menopause?

Before menopause, OSA is roughly two to three times more common in men than women. After menopause, that gap narrows substantially. Data from the Wisconsin Sleep Cohort Study found that postmenopausal women not using HRT had 3.5 times the odds of moderate-to-severe OSA compared with premenopausal women, after accounting for age and BMI.[1]

Prevalence estimates for moderate-to-severe OSA in postmenopausal women reach 20 to 25% in some population studies, though many cases are undiagnosed.[2] Several things drive this increase at menopause:

Progesterone decline. Progesterone is a respiratory stimulant that helps keep the upper airway muscles firm during sleep. It acts on the brainstem breathing centres to increase breathing drive and reduces the tendency for the airway to collapse under negative pressure. Its decline after menopause removes this protection.[3]

Estrogen decline. Estrogen supports the function of the throat muscles that keep the airway open and has some anti-inflammatory effect on airway tissue.[3] As estrogen falls, the airway is more likely to narrow during sleep.

Body composition changes. The shift of fat toward the abdomen and upper body that comes with falling estrogen includes more fat around the throat and neck, which physically narrows the upper airway.[4]

A less reliable arousal. The brain’s response to low oxygen during sleep, the brief wake-up that ends an apnea, may become less reliable with age, letting apneas last longer before the arousal happens.

Why Women’s OSA Looks Different

The textbook picture of OSA is a middle-aged overweight man who snores loudly, visibly stops breathing, and is very sleepy during the day. Clinicians trained on that picture may not recognise OSA in women, whose presentation usually differs in several ways.

Snoring is less obvious or absent. Women with OSA are more likely to have hypopneas (partial narrowing with reduced airflow) rather than complete apneas. Hypopneas produce less dramatic snoring and may not be noticed by a partner or by the woman herself.

Insomnia and staying-asleep problems dominate. Women with OSA more often present with trouble staying asleep, frequent waking, and unrefreshing sleep rather than the daytime sleepiness that marks male OSA. These symptoms overlap heavily with hot flash-driven perimenopausal sleep disruption, making it easy to blame hormones without investigating OSA.

Fatigue rather than sleepiness. Women with OSA more often report fatigue and cognitive problems (brain fog, poor concentration, memory) than the excessive daytime sleepiness that is the main criterion in standard OSA screening tools. STOP-BANG, the most commonly used OSA screening questionnaire, was validated mostly in men and has poorer sensitivity for detecting OSA in women.[5]

Mood and cognitive symptoms. OSA causes significant mood disturbance through the combination of broken sleep, repeated low oxygen at night, and nervous system activation. These symptoms are easily blamed on perimenopausal hormone changes and treated without considering OSA as a cause.

Fewer witnesses. Women are more likely to sleep alone, either permanently or when symptoms drive them to a separate room. Witnessed apneas, a key clue, are therefore reported less often by women.

Consequences of Untreated OSA

The heart consequences of OSA are well established. Each apnea produces a surge in blood pressure and heart rate. Repeated across hundreds of apneas per night over years, this produces sustained high blood pressure, damage to the blood vessel lining, raised inflammatory markers, and a higher risk of atrial fibrillation.[6]

Women with untreated OSA who do not use CPAP have higher heart-related mortality than women without OSA, and CPAP use is linked to lower risk.[8] For postmenopausal women already in a stretch of rising heart risk from estrogen loss, untreated OSA adds a substantial and treatable extra burden.

Cognitive consequences include problems with attention, working memory, and executive function that are separate from simple sleep loss. Repeated low oxygen during apneas causes oxidative stress and inflammation in brain regions involved in memory. Some research links severe untreated OSA with faster cognitive decline and higher dementia risk over long follow-up.[7]

Getting a Diagnosis

A formal diagnosis needs a sleep study. The gold standard is polysomnography (PSG) in a sleep lab, which measures brain waves, airflow, oxygen levels, breathing effort, heart rate, and limb movements. It gives the most complete picture but is resource-intensive.

Home sleep apnea testing (HSAT) uses a portable device that measures airflow, oxygen levels, and breathing effort at home. It is less complete than PSG but adequate for diagnosing most moderate-to-severe OSA. In the NHS, HSAT is the most common first-line test and is available through most sleep services.

The referral path:

  1. Raise the concern with a GP, describing specific symptoms: unrefreshing sleep, frequent night waking, morning headache, fatigue, mood or cognitive changes. Mention menopause as context but specifically ask whether OSA could be contributing.

  2. A GP can refer to a respiratory sleep service or order HSAT without a specialist referral in many NHS trusts.

  3. If an initial HSAT comes back negative but suspicion remains high, requesting a full PSG or a specialist sleep medicine referral is appropriate.

The Epworth Sleepiness Scale, commonly used by GPs to screen for sleep disorders, may underestimate OSA in women who present with fatigue rather than sleepiness. A score below the clinical threshold does not rule out OSA in a woman with consistent symptoms.

Treatment Options

Continuous positive airway pressure (CPAP) is the first-line treatment for moderate-to-severe OSA. It delivers pressurised air through a mask, acting as an air splint to keep the airway open during sleep. CPAP eliminates apneas and hypopneas in most users, restores normal sleep structure, lowers blood pressure, improves cognitive function, and reduces daytime fatigue.

CPAP works regardless of sex. Studies in postmenopausal women with OSA show similar improvements in blood pressure, daytime function, and quality of life as in men.[8]

Adherence is the main challenge: around 30 to 50% of people prescribed CPAP use it consistently. Common barriers include mask discomfort, dry mouth or nose, and trouble sleeping with the device. Most are solvable with the right equipment fit (nasal pillow, nasal, or full-face mask options) and settings adjustments such as heated humidification or auto-adjusting pressure. The first few weeks are usually the hardest; people who persist through the adjustment period usually adapt.

Mandibular advancement devices (MADs) are custom-fitted mouthpieces that move the lower jaw forward during sleep, increasing space in the throat. They are less effective than CPAP for severe OSA but appropriate for mild-to-moderate OSA or for people who cannot tolerate CPAP.

Position therapy. OSA is often worse when lying on your back, because gravity pulls the tongue and soft palate backward. Position therapy (devices that prevent back-sleeping) is appropriate for positional OSA and can supplement other treatments.

HRT and OSA. The evidence supports a protective effect of HRT against developing OSA, in line with the role of sex hormones in airway tone. Women on HRT in the Wisconsin Sleep Cohort Study had lower OSA rates than those not using it.[1] HRT does not replace CPAP for established OSA, but for women considering HRT for other reasons, lower OSA risk is one more factor in the overall balance.

Weight management. Extra fat around the throat and neck is a direct mechanical contributor to OSA. Weight loss of 10% or more can produce meaningful reductions in OSA severity, and in some cases of mild OSA, enough weight loss resolves it. Weight loss alone is not enough treatment for moderate-to-severe OSA, and delaying treatment while pursuing weight loss is not appropriate given the heart consequences of untreated disease.


References

[1] Young, T., Finn, L., Austin, D., Peterson, A. (2003). Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. American Journal of Respiratory and Critical Care Medicine, 167(9), 1181–1185. https://doi.org/10.1164/rccm.200209-1055OC

[2] Heinzer, R., Vat, S., Marques-Vidal, P., et al. (2015). Prevalence of sleep-disordered breathing in the general population: The HypnoLaus study. Lancet Respiratory Medicine, 3(4), 310–318. https://doi.org/10.1016/S2213-2600(15)00043-0

[3] Popovic, R. M., White, D. P. (1998). Upper airway muscle activity in normal women: Influence of hormonal status. Journal of Applied Physiology, 84(3), 1055–1062. https://doi.org/10.1152/jappl.1998.84.3.1055

[4] Tishler, P. V., Larkin, E. K., Schluchter, M. D., Redline, S. (2003). Incidence of sleep-disordered breathing in an urban adult population: The relative importance of risk factors in the development of sleep-disordered breathing. JAMA, 289(17), 2230–2237. https://doi.org/10.1001/jama.289.17.2230

[5] Chiu, H. Y., Chen, P. Y., Chuang, L. P., et al. (2017). Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: A bivariate meta-analysis. Sleep Medicine Reviews, 36, 57–70. https://doi.org/10.1016/j.smrv.2016.10.004

[6] Drager, L. F., Togeiro, S. M., Polotsky, V. Y., Lorenzi-Filho, G. (2013). Obstructive sleep apnea: A cardiometabolic risk in obesity and the metabolic syndrome. Journal of the American College of Cardiology, 62(7), 569–576. https://doi.org/10.1016/j.jacc.2013.05.045

[7] Lutsey, P. L., Bengtson, L. G., Punjabi, N. M., et al. (2016). Obstructive sleep apnea and 15-year cognitive decline: The Atherosclerosis Risk in Communities study. Sleep, 39(2), 309–316. https://doi.org/10.5665/sleep.5434

[8] Campos-Rodriguez, F., Martinez-Garcia, M. A., de la Cruz-Moron, I., Almeida-Gonzalez, C., Catalan-Serra, P., Montserrat, J. M. (2012). Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: A cohort study. Annals of Internal Medicine, 156(2), 115–122. https://doi.org/10.7326/0003-4819-156-2-201201170-00006

Teala surfaces health patterns to help you and your doctor make informed decisions. It does not diagnose conditions or replace medical advice. Always consult a qualified healthcare professional about your symptoms and treatment.